Phase 1 Clinical Trial Unit for Therapeutics
$249,129N01FY2013AINIH
Dynport Vaccine Company, Llc, Frederick MD
Investigators
Abstract
The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic agents for the treatment of infectious disease.
View original record on NIH RePORTER →